Saffron, one of the world’s most expensive and potent spices, is now a viable supplement for Canadians affected by age-related macular degeneration (AMD) and cataracts, the two leading causes of vision loss in the country. A number of studies have proven the retinal protective effects and vision improvement properties of saffron in patients with AMD.
Health Canada has officially approved of Saffron 2020, an eye supplement that combines saffron with other nutrients known to positively impact eye health. Saffron 2020 is the only supplement to be approved for cataracts and macular degeneration by Health Canada.
Saffron 2020 was formulated following studies in Italy and Australia showing the benefits of saffron in patients with AMD. This natural health product helps to maintain our invaluable eyesight in AMD and cataracts, and also helps to reduce the risk of developing cataracts.
According to Dr. Kim Julian, a top eye surgeon involved in the elaboration of Saffron 2020, there is no cure available for AMD at this time. “Saffron 2020 is the only supplement I’m aware of which combines saffron with important eye health nutrients like resveratrol, zinc, antioxidant vitamins (A, B2, C and E) and natural carotenoids lutein and zeaxanthin.”
Saffron 2020 is a patent pending product from Groupe Persavita located in Montréal. Further information on the supplement, AMD, and cataracts is available on the product’s website.